Today's deal net contains news from PGDx, Notch Therapeutics, Quell Therapeutics, SpyBiotech, Vision Medicals, Future Meat Technologies, BusUp and Advanced Chemotherapy Technologies.
Personal Genome Diagnostics (PGDx), a US-based cancer diagnostics developer spun out of Johns Hopkins University, secured $103m yesterday in a series C round led by investment firm Cowen Healthcare Investments. PFM Health Sciences, Rock Springs Capital, Sands Capital, Vensana Capital, Windham Ventures, Catalio Capital Management, Innovatus Capital Partners, Kern Capital, New Enterprise Associates (NEA) and Northpond Ventures also participated in the round. PGDx is working on genome and tissue-based oncology analysis technology designed to help healthcare professionals provide personalised therapies…
Thierry Heles
Thierry Heles is the editor of Global University Venturing, host of the Beyond the Breakthrough interview podcast and responsible for the monthly GUV Gazette (sign up here for free).
